Trial Profile
Study investigating quantitative role of hepatitis B surface antigen (HBsAg) in Hepatitis B patients treated with tenofovir
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 04 Dec 2015 New trial record